Radio
Now Playing
Quickyla Radio — Click to play
Open →
Radio
Now Playing Quickyla Radio — Click to play
Open Radio →
Breaking
New weight loss pill approved for use in UKStarbucks is ending GLP-1 coverage for weight loss as employer costs climbPfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegov…Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO saysNovo Nordisk stock falls after raised forecast fails to change the debate over its obesit…

Choose Language

Select a language for news translation.

Results for "Wegovy" 8 articles

No stories found

New articles are fetched every 25 minutes. Refresh

Markets
S&P 5005,432.18▲ 0.42%
NASDAQ17,891.40▲ 0.87%
DOW39,118.86▼ 0.15%
BTC$67,842▲ 2.14%
ETH$3,291▲ 1.38%
GOLD$2,341/oz▼ 0.31%
OIL (WTI)$82.14▲ 0.67%
EUR/USD1.0842▼ 0.09%
GBP/USD1.2641▲ 0.22%
NIKKEI38,471▲ 1.02%
FTSE 1008,218▼ 0.28%
Full Markets →
Local Weather
—°F
Local area
58% 12 mphH:78° L:61°
Emergency Alerts
{# These used to be hardcoded, permanently-displayed example alerts ("Wildfire Warning... until 8PM") with no real data source — that's fabricated safety information shown to every visitor regardless of actual conditions. Removed rather than left live; a real version needs a genuine feed (e.g. the free NWS alerts API) behind it. #}
No active alerts for your area right now.
✦ AI Powered
Summarize any article instantly
Get 30-second summaries, bullet points, deep analysis, or a child-friendly version — powered by AI.
30-sec summary Bullet points Deep analysis
✦ Based on Your Interests
Trending stories you might like
Sign in to personalize
Around the World
▶ Video News
🏥 Health
4 hours ago
UK approves Eli Lilly’s Foundayo for weight loss
BBC Health · ▶ Watch
🏥 Health
5 hours ago
Aleniglipron pill delivers 12% weight loss in 36 weeks
ScienceDaily · ▶ Watch
📈 Markets & Finance
2 days ago
Starbucks ends GLP-1 drug coverage for workers
Business Insider Mkt · ▶ Watch
📈 Markets & Finance
3 days ago
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Nasdaq News · ▶ Watch
💰 Business
5 days ago
Bank of America invests $250 million annually in employee GLP-1 drugs
CNBC Finance · ▶ Watch
💰 Business
5 days ago
Novo Nordisk shares drop 4.3% despite raised full-year guidance
CNBC Earnings · ▶ Watch
🏥 Health
6 days ago
Brain Biology Triggers Hunger to Regain Lost Weight
ScienceDaily · ▶ Watch
📈 Markets & Finance
12 days ago
I've traveled extensively while on a GLP-1. I wish someone had told me a few things before my first trip.
Business Insider Mkt · ▶ Watch
Religion & Culture More →
Islam Christianity Hinduism Judaism Sikhism Interfaith Culture

More to Read

New weight loss pill approved for use in UK
🏥 Health
UK approves Eli Lilly’s Foundayo for weight loss
BBC Health · 4 hours ago
New GLP-1 pill delivers up to 12% weight loss in 36 weeks
🏥 Health
Aleniglipron pill delivers 12% weight loss in 36 weeks
ScienceDaily · 5 hours ago
Starbucks is ending GLP-1 coverage for weight loss as emplo…
📈 Markets & Finance
Starbucks ends GLP-1 drug coverage for workers
Business Insider Mkt · 2 days ago
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks U…
📈 Markets & Finance
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordi…
Nasdaq News · 3 days ago
Bank of America spends $250 million a year on GLP-1 drugs f…
💰 Business
Bank of America invests $250 million annually in employee GLP-1 drugs
CNBC Finance · 5 days ago
Novo Nordisk stock falls after raised forecast fails to cha…
💰 Business
Novo Nordisk shares drop 4.3% despite raised full-year guidance
CNBC Earnings · 5 days ago
Your brain may be wired to regain lost weight
🏥 Health
Brain Biology Triggers Hunger to Regain Lost Weight
ScienceDaily · 6 days ago
I've traveled extensively while on a GLP-1. I wish someone …
📈 Markets & Finance
I've traveled extensively while on a GLP-1. I wish someone had told me a few th…
Business Insider Mkt · 12 days ago
Full view